OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Giacomo Koch

4 Projects | 1 Researchers | $5,463,300 Invested

2024

NeuroScios GmbH

Giacomo Koch, MD, PhD

Phase 3 trial of dopaminergic therapy in patients with Alzheimer’s disease.

  • Funding Amount: $3,809,420
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Active

2020

Santa Lucia Foundation

Giacomo Koch, MD, PhD

Phase 3 trial of dopaminergic therapy in patients with Alzheimer’s disease.

  • Funding Amount: $801,080
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2019

Santa Lucia Foundation

Giacomo Koch, MD, PhD

Dopaminergic Therapy for Frontotemporal Dementia Patients.

  • Funding Amount: $602,800
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2015

Santa Lucia Foundation

Giacomo Koch, MD, PhD

Dopaminergic therapy for Alzheimer's disease patients.

  • Funding Amount: $250,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed